Key result
A complete percutaneous approach for transfemoral TAVI yielded similar 1-year rates of combined mortality, bleeding, or vascular complications compared to surgical cutdown.
Why the study?
Does a complete percutaneous vascular access approach reduce combined adverse events compared to a surgical cutdown approach in patients undergoing transfemoral TAVI?
Observational (n=402)
Yes
Does a complete percutaneous vascular access approach reduce combined adverse events compared to a surgical cutdown approach in patients undergoing transfemoral TAVI?
Complete percutaneous access and surgical cutdown provide similar safety and effectiveness at 1 year for patients undergoing transfemoral TAVI.
Answers are grounded in this paper and cite their sources.
May support percutaneous access as alternative to cutdown in transfemoral TAVI; leaves open randomized confirmation.
OBJECTIVE: To compare the 1-year outcomes of complete percutaneous approach versus surgical vascular approach for transfemoral transcatheter aortic valve implantation (TAVI), among "real-world" patients from the multi-center Brazilian TAVI registry. BACKGROUND: Vascular access still remains a major challenge for TAVI via transfemoral approach. Vascular access through complete percutaneous approaches or through open surgical vascular techniques seems to be acutely similar. However, the long-term outcomes of both techniques remain poorly described. METHODS: The study population comprised all patients treated via transfemoral route in the Brazilian TAVI registry, a "real-world", nation-based, multi-center study. Patients were divided according to the initial vascular access approach (percutaneous vs. surgical) and clinically followed-up for 1 year. The primary endpoint was the incidence of combined adverse events all-cause mortality, life-threatening bleeding, and/or major vascular complication at 1 year. RESULTS: A total of 402 patients from 18 centers comprised the study population (percutaneous approach in 182 patients; surgical cutdown approach 220 patients). The incidence of combined adverse events was not different in the percutaneous and the surgical groups at 30 days (17.6% vs. 16.3%; P = 0.8) and at 1 year (primary endpoint) (30.9% vs. 28.8%; P = 0.8). Also, the study groups overall were comparable regarding the incidence of each individual safety adverse events at 30 days and at 1 year. CONCLUSION: Total percutaneous techniques or surgical cutdown and closure may provide similar safety and effectiveness during the first year of follow-up in patients undergoing transfemoral TAVI.
No takes yet. Share an insight, caveat, or question.
Bernardi et al. (2015) conducted an observational in Transfemoral transcatheter aortic valve implantation (TAVI) (n=402). Complete percutaneous approach vs. Surgical cutdown approach was evaluated on Combined adverse events all-cause mortality, life-threatening bleeding, and/or major vascular complication at 1 year (p=0.8). A complete percutaneous approach for transfemoral TAVI yielded similar 1-year rates of combined mortality, bleeding, or vascular complications compared to surgical cutdown.
Synapse has enriched 10 related papers. Consider them for comparative context: